Market Research Blog

Future Market Insights (FMI) recently published a market research report, titled, Identity & Access Management Market – Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018-2028. According to the report, the identity and access management market is set to witness strong Y-o-Y growth in 2019, at approximately 9% over 2018.

With an estimated incremental opportunity of over US$ 17 billion between 2018 and 2028, the global market for identity and access management is likely to observe an impressive growth outlook in years to come. Rapid increase in cybercrime prevalence is necessitating effective and efficient IT security measures, which is primarily driving the identity & access management market.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9483

Public Domain, IT & Telecom, and Finance & Insurance – Key End Use Industries

While several business verticals have been focused on heavy investments in physical identity management, it is highly likely that operators in public domain, finance and insurance sectors, and IT and telecom will continue to account for significant revenue shares in global market for identity and access management, in the near future.

As suggested by the report, the collective share of public administration, finance and insurance, and IT and telecom companies in the global market value roughly equates 60%. Healthcare and media industries are positioned as the next lucrative end use segments for providers of IAM services and solutions.

Approximately 60% of Demand Is Generated by Large Enterprises

As the demand for next-generation security solutions is constantly on rise, as reported in the recent past, the demand for identity and access management solutions will remain higher when compared to that for identity and access management services. Currently, a wide range of identity and access management solutions accounts for over 60% of the total market value, as indicated by FMI’s study.

Among multi-factor authentication, single sign-in, access security, and directory management, a majority of consumers will continue to generate demand for directory management and access security.

On-premise deployment of identity and access management solutions currently accounts for more than 55% of the overall global IAM deployment. Moreover, FMI’s analysis has envisaged a massive incremental opportunity of over US$ 17 billion for cloud-based IAM, over 2018-2028. On the other side, the cloud-based deployment of identity and access management will reportedly see an average yearly growth at over 10%, over the course of coming years.

With incessantly rising rate of implementation of advanced and next-generation technologies such as AI, machine learning, and advanced biometric technologies at enterprises, the demand for reliable identity and access management services and solutions is also increasing. FMI’s analysis concludes that a considerable number of enterprises are following the trend of adoption of identity and access management. While large enterprises continue to account for a substantial share of around 60% of the overall demand generated for identity and access management, the report has highlighted rapid growth in the market value share of SMEs.

Key Providers to strategize on Integration of Next-gen Technologies

The regional evaluation of identity and access management market reveals that North America will remain dominant in the long run owing to rapidly strengthening base of next-generation technological advancements. China, however, on the other side, has recently earned the title of one among the world’s most connected countries. According to FMI’s analysis, China’s identity and access management market is an important investment pocket for IAM services and solutions providers. Europe will also be one of the target markets for participants in the identity and access management landscape, which the report has attributed to favorable promotional support from European governments to adoption of advanced security systems.

Some of the key companies competing in the global identity and access management market research report include BeyondTrust, Bomgar (Lieberman Software Corporation), CA Technologies, Core Security, CyberArk, Dell, ForgeRock, Gemalto, Hitachi ID Systems, IBM Corporation, and Microsoft Corporation. The report has covered in-depth strategic profiles of some of the most prominent market players.

A large number of small and medium sized businesses are exclusively investing in reliable IT security and R&D, which makes SMEs the target area of investment for IAM services and solutions providing companies. Moreover, to cater to ever-growing demand for improved data security, identity and access management services and solutions providers are focusing on integration of machine learning and behavioral analytics capabilities into their IAM offerings.

Key Segment

By Component

• Solution
  • Multi-Factor Authentication
  • Single Sing-in
  • Access Security
  • Directory Management
• Services
  • Consulting Services
  • Integration and Deployment Services
  • Maintenance and Support Services

By Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

By Deployment

• On-Premise
• Cloud

By End User

• Small and Medium Enterprises (SMEs)
• Large Enterprise

By Vertical

• Finance and Insurance
• Information (Telecom and IT)
• Public Administration
  • Government
  • Military and Defense
• Scientific and Technical Services
• Health Care and Social Assistance
• Transportation and Warehousing
• Media and Entertainment
• Manufacturing

To gain more insights into the market with a detailed table of content and figures, click here: https://www.futuremarketinsights.com/toc/rep-gb-9483

Identity and Access Management Market Structure Analysis

• The global identity and access management market represents a moderately consolidated competition landscape, wherein Tier 1 companies hold a revenue share of approximately 38%.
• While most of the key players maintain a strategic focus on the North America, Europe, and East Asia markets, the report underscores that technology assessment will be an important developmental strategy for companies.
• Leading players in the identity and access management market are also concentrating on entering strategic partnerships and collaborations with other security system providers, which is underscored as a strong differentiation strategy.

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

According to the latest research by Future Market Insights, the glucagon injectable market is set to experience 5.4% growth during the year 2021-2031. Glucagon is a hormone that mobilizes the glucose in the blood circulation, through the breakdown of glycogen to glucose. Deficiency of this hormone causes a condition called hypoglycaemia.

To treat hypoglycaemia, glycogen injections and tablets are given to the patients. Glycogen injections are used for the treatment of severe hypoglycaemia and diagnostics purposes. In diagnostics, it is used for radiographic examination of the small bowel, duodenum, colon and stomach when diminished intestinal motility would be advantageous. The glucagon injectable market is mainly driven by an increase in the prevalence of type 1 and type 2 diabetes, new product launches and hypoglycaemia unawareness.

What is the Driving Demand for Glucagon Injectable?

Glucagon injections are used to treat severe hypoglycaemia and for diagnostics purposes. The growth of this market is anticipated due to the rise in prevalence of diabetes, unawareness about hypoglycaemia and new product launches by the market players.

According to the International Diabetes Federation report, by 2045, globally there will be 700 million people between 20-79 years who will be suffering from diabetes. On average a person having type 1 diabetes suffers at least 2-3 episodes of hypoglycaemia in a week. This acts as a driver for the glucagon injectable markets. Sometimes people having blood sugar levels below 70 mg/dL and do not experience any symptoms.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14042

This is called hypoglycaemia unawareness and these people are at a higher risk of any severe hypoglycaemia episode. According to a study conducted by the HAT Brazil study group 20.6% and 10.6% of people with type 1 and type 2 diabetes respectively showed asymptomatic hypoglycaemia. This acts as a driver for the market. The companies are investing in the research and development of glucagon injectable and for their approval. For instance, in December 2020, FDA approved the first generic glucagon injection for the treatment of hypoglycaemia and diagnostics aid.

Impact of COVID on Glucagon Injectable Market

The COVID-19 has impacted the glucagon injectable market. Due to the pandemic, the research and development were mainly carried out in the field of COVID. Due to this shift, the research of glucagon injectables was affected.

Also, with the change in lifestyle and eating habits, the prevalence of diabetes has increased. Therefore, putting people at a higher risk of diabetes and hypoglycaemia. Hence, COVID-19 had both positive and negative impacts on the glucagon injectable market.

Regional Demand Outlook for Glucagon Injectable

The glucagon injectable market is dominated by the North American region. This is due to the presence of the leading market player, the availability of glucagon injectable and the growing geriatric population. According to a UN report, the geriatric population will increase from 9.3 per cent in 2020 to around 16.0 per cent in 2050. Due to the combined effect of impaired pancreatic islet function and increasing insulin resistance with ageing, this population are at a higher risk of developing type 2 diabetes.

These factors drive the market in this region. Also, the expiration of patents of leading drugs is expected to surge the demand of the market. Followed by North America, Europe and Asia is dominating the glucagon injectable market. This is due to the presence of key market players in Europe and the increasing geriatric population.

For instance, as per Eurostat reported data in 2020, more than 20 % of the total population of Europe is above the age of 65. Moreover, awareness about the current treatments by the population plays a crucial role in the surge in demand for the glucagon injectable market during the forecast period.

Who are the Key Manufacturers and Suppliers of Glucagon Injectable?

The manufacturers and suppliers of glucagon injectables are

• Fresenius SE & Co. KGaA
• Xeris Pharmaceuticals Inc
• Novo Nordisk A/S
• ILS.Inc
• Amphastar Pharmaceuticals Inc.
• Lilly USA
• LLC. Zealand Pharma A/S.
• Avalon Pharma Pvt. Ltd

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14042

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to the latest research by Future Market Insights, the Faecal Calprotectin Testing Market will witness growth during 2021-2031. With current researches paving the path for further in depth study which will give minimum discomfort to the victims of this disorder are a positive sign for the faecal extraction systems market.

With increase in prevalence of inflammatory bowel syndromes and cancer, this market will receive boost due to scientists’ will to find new ways to treat diseases in the forecast period to the global market.

What is Driving Demand for Faecal Calprotectin Testing Market?

Crohn’s disease and ulcerative colitis come under the gambit of inflammatory bowel syndromes. Calprotectin is a serum which is present at site of any kind of inflammation; hence it is also called as an inflammatory marker or biomarker. Making IBS a major driver in this testing market. Changes in calprotectin levels of a faecal sample can play a major role in identifying the bowel syndromes which cause inflammation, making it a major driver of the market.

The capability of calprotectin to be able differentiate between irritable bowel syndrome and inflammatory bowel syndrome makes is a most impactful driver of this market. This uniqueness of calprotectin makes it swift in detection and treatment of bowel related diseases.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14039

Constant alteration in the diet of individuals raise the risk of IBS and increase an individual’s susceptibility towards it. A more detailed study to understand this relation will definitely assist in making necessary changes in its testing and act as a driving factor.

Prediction of post-operative recurrence of Crohn’s disease –

As published by researchers in the Digestive and Liver Disease Journal in May 2020, faecal calprotectin has a potential application in detecting the reoccurrence of Crohn’s disease.

As established earlier, Calprotectin presents itself at the site of any kind of inflammation and is therefore known as an inflammatory biomarker. This recent study shows that this serum can also act as predictive indicator in some cases. Variation in its levels in the patients with history of Crohn’s disease proved to be an indicator of recurrence of the disease. This and many future findings will help in making individuals actively do the testing and hence give a boost to the market.

U.S. and Canada Faecal Calprotectin Testing Market –

According to Centre for Disease Control, colorectal cancer ranks 4^th among the top 10 cancer prevalence in US. Investments and government support in conducting research in various verticals will definitely attract more attention to the faecal calprotectin market.

Developments like these showcases the encouragement provided by the authorities in developing novel systems. This will definitely aid U.S in dominating the market as there is an increase in importance of detection, prevention and treatment disease will further boost this market.

Europe Faecal Calprotectin Testing Market –

European region seems to be at the front for faecal calprotectin testing. Looking at the recent developments, European authorities tend to focus on encouraging exploration of new applications in any section of healthcare sector. A very peculiar study published in the Scandinavian Journal of Gastroenterology, explored the application of calprotectin faecal testing in diagnosis of colorectal cancer, as abdominal complaints are quite common in colorectal cancer patients.

Another interesting development which makes Europe a leading market in this market, is a study conducted with an attempt establish a connection between dermatological complications and faecal calprotectin. According to this Journal of Clinical and Experimental Dermatology published article, skin lesions are very common occurrence in inflammatory bowel syndrome (IBS). Given the sensitivity of the serum calprotectin towards inflammation, proper targeted testing done in this direction will definitely give a boost to this market.

Who are the key manufacturing and supplying companies in Faecal Calprotectin Testing Market?

Key Players:

• ALPCO
• Alpha Laboratories
• bioMérieux SA
• Canvax Biotech
• DRG Instruments GmbH
• Promega Corporation
• Svar Lifescience (CALPRO)
• Arbor Assays
• Werfen
• BUEHLMANN

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14039

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to the latest research by Future Market Insights, the osteoarthritis gene therapy market is expected to grow at a CAGR of 8.7%. The demand outlook is anticipated to develop steadfast during the forecast period.

The providers of this therapy are expected to go through a high demand phase that would offer them various opportunities for progress.

What are the major drivers of the Osteoarthritis Gene Therapy demand?

Osteoarthritis (OA) is one of the leading cause of disability in the western world. According to the Osteoarthritis Foundation International, the prevalence of OA is approximately 500 million people, globally.

The disease is characterized by being incurable, incurring immense treatment cost but responding very poorly to the treatment. The fact that OA is a debilitating disease and gene therapy provides a hope for treatment and pain reduction, there is a very high demand for this therapy, globally. This is one of the major driver for this market.

The presence of a large number of geriatric and target patients, as well as improved healthcare infrastructure in several countries in the Asia-Pacific region, is expected to open up market opportunities during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14033

CRISPR/Cas9 system: The latest technique in gene therapy

A novel approach to gene editing using the CRISPR / Ca9 system bypasses disease-causing mutations in a gene, providing treatment for single-gene-related genetic diseases such as cystic fibrosis, certain types of sickle cell anemia and other rare diseases.

The CRISPR / Ca9 system has created promising new therapies for genes that can target and correct disease-causing mutations in a gene. In this process, Cas9 – a bacterial protein – cuts DNA at a specific location where it can edit, trim the genetic sequence, or insert a new sequence before repairing the DNA.

U.S. and Canada: Osteoarthritis Gene Therapy demand outlook

The Osteoarthritis gene therapy market in the U.S. and Canada regions is expected to be slightly affected due to the COVID-19 pandemic. The demand is supposed to show slight growth due to the government investments in various R&D activities in cell based research.

Since the gene therapy can be personalized for every patient’s need, this is anticipated to drive the demand outlook in these regions.

Europe: Osteoarthritis Gene Therapy demand outlook

The European region dominated osteoarthritis gene therapy market during the year 2020. This can be attributed to various reasons that contribute to the demand of this therapy such as rising prevalence of osteoarthritis cases in the region, increased geriatric population due to increased access to advanced medical care and rising obesity rates in various countries of Europe.

Who are the key players in the Osteoarthritis Gene Therapy market?

The key players in osteoarthritis gene therapy demand outlook are

• Flexion
• GeneQuine
• Novartis
• Smith & Nephew
• Genascence
• Kolon TissueGene
• Sanofi
• Paraxel
• Medipost co ltd
• and Mundipharma.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14033

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

The SGLT2 Inhibitors Treatment market is looking forward to grow at a higher rate in the forecast period of 2021-2031. SGLT2 Inhibitors help in reabsorption of glucose from the kidney leading to low blood glucose level.

SGLT 2 inhibitors is said to grow the market in the near future as the consumption of the antidiabetics drugs is taking a spike. These have high consumption rate as the prevalence of type 2 diabetes across the globe is never-ending, thus leading to grow the market. The prevalence of people suffering from Diabetes is said to lead the market at another level.

What is driving Demand for SGLT2 Inhibitors Treatment Market?

The demand for this market has seen at a higher rate at a global level as there has been increase in the number of Diabetic cases with increase in the population. According to WHO data worldwide, the count in the cases is seen at a higher side i.e. from 2.8% in 2000 and by 2030 it is said to be 4.4%. According to the 29.1 million cases of people diagnosing with diabetes in the year 2010.

The changing lifestyle, obesity and sedentary lifestyle can be the causes for diabetes can demand the SGLT2 market. Population preferring simple and easy way of treatment can boost the market. Covid 19 has eventually driven the market growth as post covid complications has made it a necessity.  In addition, new combination drugs seems to drive the market. US and Europe has the highest number of morbid obesity cases which leads to Diabetes, can be the driving factor for the market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14054

U.S. SGLT2 Inhibitors Treatment Market Outlook

• North America occupies about 65% of the market share. US accounts for the highest number of type 2 diabetic cases owing to demand in the market growth. North America also has well established health a care structure. Canagliflozin saw an immense growth in the US, which was approved by US FDA. According the study on an average of 1.75 million US native is diagnosed with type 2 Diabetes, furthermore the population suffering from morbid obesity is one of the major reason to cause Diabetes. This gives us an open window to drive our market.

Europe Demand Outlook for SGLT2 Inhibitors Treatment Market

Empagliflozin is said to be the leading the market in Europe region and can be used in adults with low adverse effect. European commission has granted permission to market the product globally. EMPOWER program has been run so as to understand the efficacy of the Empagliflozin, this was brought in by Boehringer Ingelheim and Lilly.

Empagliflozon was the recent medicine to be approved by FDA in 2014. European Medicine Agency confirms that the SGLT 2 inihibitors can be used in treatment of Type 2 Diabetes. Europe has the highest rate of Diabetes cases which is fatal in nature and in the given forecast period it is said to reach an average of 10million cases.

Who are the Key Manufacturers and Suppliers of SGLT2 Inhibitors treatment market.

Some of the key players operating in the SGLT2 Inhibitors Treatment Market are

• Eli Lilly and Company (The U.S),
• C.H. Boehringer Sohn AG & Ko. KG (Germany),
• Johnson & Johnson (The U.S),
• AstraZeneca plc (UK),
• The Merck Group (Germany),
• Pfizer Inc. (The U.S),
• Tecnimede Group (The U.S),
• Unichem Laboratories Ltd. (India), and
• Edifício Bluepharma (Portugal).

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14054

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to the latest research by Future Market Insights, the Pancreatic Elastase Testing Market will undergo a steady growth during 2021-2031. A gradual increase due to constant research studies being conducted and new verticals of disease treatment being opening can be seen over the mentioned forecast period.  The increasing innovations and advancements in developing new therapeutic techniques and products will further boost the market.

What is Driving Demand for Pancreatic Elastase Testing Market?

Pancreatic elastase is a type of enzyme secreted by the pancreas. This enzyme breaks down fats, proteins, carbohydrates, etc. as it plays a crucial role in the digestion process.

Changes in level of pancreatic elastase helps in determining whether the pancreas are functioning in a proper manner or not. Decrease in its level indicates towards insufficiency of the pancreas.

The prominent drivers in this market are the rising levels of fat in individuals due to sedentary lifestyle and increased alcoholism most probably due increase in competition among individuals which can lead to severe stress levels.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14047

A study was published in Oxford Academic in 2016 which ventured into analysing the relationship between pancreatic elastase and diabetes mellitus. The researchers used ELISA for determining PE levels in the patients with diabetes mellitus. They concluded that, there exists a strong association between the changes in PE levels and diabetes mellitus.

Individuals affected with diabetes mellitus showed a significant decrease in amount of PE. This discovery can potentially be used to detect diabetes in suspected individuals with the help of early testing so that proper management of the disease can be done.

Diagnostic and therapeutic approach towards pancreatic insufficiency

Pancreatic insufficiency can be caused due to various types of pancreatic diseases like chronic pancreatitis, acute pancreatitis. Pancreatitis causes about 86,000 hospital admissions per year in United States. This makes it even more important to explore different and new approaches towards its management.

A study was published in Wiley Online Library which aimed to find out if a more therapeutic and diagnostic approach could be taken in treating a pancreatic insuffiency post pancreatitis. According to their findings, early diagnosis has many merits here as it prevents future complications in malabsorption of nutrition and leads to an adequate as well as timely treatment. This can be achieved with proper and timely testing of PE.

They further summarized that proper improvements in the diet will lead to maintaining of a nutritional status as per the normal values, but also avoid any complications associated with malabsorption of these nutrients.

U.S. and Canada Pancreatic Elastase Testing Market –

According to data given by American Addiction Centres, 95,000 American dies every year i.e. 261 per day die due to alcohol-related complications. Alcohol plays a major role in causing pancreatitis, which ultimately leads to pancreatic insufficiency.

This is what makes US the second most lucrative market is that of North American region. The main contributing factor behind the steady growth of this market is the availability of advanced facilities at healthcare centres.

Europe Pancreatic Elastase Testing Market –

Europe leading the pancreatic elastase testing market can be credited to continuous encouragement for the researchers in doing research and inventions related to various healthcare verticals.

For instance, ScheBo Biotech AG from Germany, inventors there created a test kit in 2021 consisting of a pancreatic elastase 1-specific antibody along with a device for sample collection and a proprietary extraction buffer.  It can detect levels of elastase in faeces at a much higher accuracy than the present kits.

Who are the key manufacturing and supplying companies in Pancreatic Elastase Testing Market?

Key players:

• Novozymes
• DuPont
• AB Enzymes
• DSM
• Aum Enzymes
• BASF
• Buhlmann Diagnostics Corp
• Bioserv Diagnostics
• CHR Hansen
• Kemin
• avail

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14047

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to the latest research by Future Market Insights, Connected healthcare market is set to experience 15.6% growth during the year 2021-2031. Due to need for effective communication.

What is driving Demand for Connected healthcare market?

Growth in the incidence rate of injuries in all age groups is one of the major factors driving the growth of connected healthcare market.  Various activities such as trekking and adventure sports further results in abrasion, minor injuries, multiple cuts and wounds on different body parts. In such cases, elastic bandages are use while the treatment procedure takes place.

Moreover, rising count of road accidents has increased significantly worldwide. These accidents can be considered as fatal or non-fatal injury, some of these non-fatal injuries require speedy application of bandages in order to stop any further damage

For instance, according to Stanford children’s health approx. number of around 3.5 million children’s of around 14 years and below get injured while playing sports or doing any adventurous activity

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14107

Elastic Bandages used for upper limbs and lowers is likely to augment connected healthcare market. 

For lower limbs, the elastic bandages are used for the treatment of hairline fracture, joint dislocation, cure factures, ankle sprains, orthopaedic procedures, varicose veins, deep cuts, accidental amputations, thigh cramps and muscle pulls. Bandages for lower limbs are majorly used by the athletes and its sales in the market is quite significant during sports season such as Olympics, national games and international games.

For the purpose of upper limbs, bandages are used widely for the treatment of hairline fractures, joint dislocation, acute injuries and swelling, it further offers support to injured soft tissues. They are widely used in cases of elbow figure eight, hand wrist figure eight along with compression dressings.

U.S. and Canada Connected healthcare market Outlook

U.S. and Canada are expected to have the highest share and therefore will dominate the connected healthcare market. This is due to the increasing orthopaedic injuries, upward trend growth rate in the surgeries and prevalence of chronic wounds are further resulting in the growing usage of elastic bandages along with medical tapes in this region.

Europe Demand Outlook for Veterinary Home Diagnostics

The European market for veterinary home diagnostics is estimated to grow at a considerable rate during the forecast period. This surge in growth is due rising geriatric population with venous diseases in this region. Th growing prevalence of deep vein thrombosis, lymphedema and chronic leg ulcers has further significantly increased the use of elastic bands in this region

Moreover, the presence of various key players in this region along with easy availability of elastic bandages is contributing positively towards the market growth. Furthermore, rising awareness of compression therapy, along with the increasing usages of elastic bandages and expansion of various key players in this region uplifts the market growth of elastic bandages in this region.

Who are the Key Manufacturers and Suppliers of Veterinary Home Diagnostics?

Some of the key players operating in the Connected healthcare market are

• 3M
• CardinalHealth
• Avcor Health Care
• Tetra Medical Supply Corp
• Patterson Medical
• DJO Global
• Paul Hartmann
• Medtronic

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14107

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to the latest research by Future Market Insights, Heating Pads Market is set to experience 6.5% growth during the year 2021-2031. The growth of veterinary home diagnostics is attributed due to lack of physical exercises, sedentary and changing lifestyle along with increasing prevalence of chronic pain in major parts of the body such as neck, back and knees uplifts the heating pad market.

What is driving Demand for Heating Pads Market?

Due to surge in Changes in lifestyle of people, lack of exercises and prevalence of chronic pain stimulates industrial expansion of heating pads. Moreover, growing number of obese people and individual with sedentary lifestyle is growing across the globe, which further increase the possibility of chronic pain in different part of the body and its treatment with the help of the heating pad.

Growing demand for heating due to lifestyle changes, pain reduction, increased mobility, reducing stiffness and restore flexibility and growing usage of heating pads as they uplift the oxygen flow and nutrients to the muscles which further helps in muscle recovery, these are considered to be some important factors enhancing the market growth of heating pads.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14104

Heating Pads cannot be used during Pregnancy which Restricts the Market growth of Heating Pads

Every positive aspect has a negative aspect as well, in case of heating pads, these pads cannot be used during pregnancy period and muscle strains which further hampers the market of heating pads over the forecast period. Sometimes, abnormal body thermoregulation is experienced while using heating pads which acts as the major disadvantageous factor offered by heating pads. Moreover, heating pads emit heat which makes them dangerous when used in an inappropriate manner. For instance, a heating pad can get hot as much as 180 degrees which can further cause third degree burns which will require skin grafting.

Heating pads, pose a burning risk for people with diabetes. Therefore, usage of heat therapy immediately aftermath of an injury is restricted. It is due to heat can cause more swelling along with tissue injury.

U.S. and Canada Heating Pads Market Outlook

U.S. and Canada are expected to have the highest share and therefore will dominate the Heating Pads Market. This is due to the increasing and vast population along with prevalence of back and shoulder pain due to long working hours are anticipated to contribute to the speedy development of the heating pad market. Many U.S. brands have formed up various alliances with Chinese ODM/OEM producers, which further makes China a key producer in the heating pad market.

Europe Demand Outlook for Heating Pads Market

The European market for Heating Pads Market is estimated to grow at a considerable rate during the forecast period. This surge in growth is due to the changing lifestyle of people, lack of physical activities increases the demand for heating pads as they are helpful in muscle recovery. Furthermore, growing prevalence of chronic physical pain in the body also upsurges the demand for heating pads in this region. Furthermore, increment in oxygen flow and nutrients to the muscle is also considered to be one of the factor which uplifts the market of heating pads.

Who are the Key Manufacturers and Suppliers of Veterinary Home Diagnostics?

Some of the key players operating in the Heating Pads Market are

• Sunbeam
• Carex
• Thermalon
• Milliard
• Nature Creation
• Beurer
• Drive Medical
• Kaz
• Walgreens

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14104

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to the latest research by Future Market Insights, HBsAg Testing market is set to witness a 5.9% growth during the year 2021-2031.

The market has been increasing at a gradual rate and is projected to witness lucrative growth due to increase in cirrhosis and liver cancer deaths due to prevalence of hepatitis B, technological advancements in diagnostic kits and due to increase in cirrhosis and growing awareness regarding early detection of hepatitis B.

What is Driving Demand for HBsAg Testing?

Hepatitis B is a potentially fatal infection and has turned into a vital healthcare problem across the world. Rise in prevalence of hepatitis B and need for early detection of hepatitis B are primary factors supporting the market growth.

In addition, rise in awareness among the population; and increase in initiatives by non-profit organizations and governments add to the development of the market. Increase in awareness among the patients’ leads to early detection of the disease. This is driving the demand for HBsAg testing.

Growing research and innovation, rise in healthcare expenditure and urbanization is resulting into rapid adoption of testing procedures, which in turn leads to market growth.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14155

Rising cases of Hepatitis B, likely to increase the HBsAg Testing Sales

Hepatitis B is an infection of worldwide importance, with a projected of 296 million people living the virus globally, according to the data provided by WHO. In the year 2019, hepatitis led to 820 000 deaths, majorly from complications such as cirrhosis and hepatocellular carcinoma.

The occurrence of hepatitis B is highest in the African and Western Pacific regions where 6.1% and 6.2% respectively of the adults are infected. Hepatitis B can lead to chronic infection and show a high risk of mortality. It is projected that 80-90% of the newborns infected with hepatitis B in first year of life suffer from chronic infections.

There is rise in prevalence of hepatitis B also because of the growing urbanization and environmental changes because of the changing lifestyle. These factors create a lucrative opportunities for hepatitis B diagnostic test manufacturers.

US and Canada HBsAg Testing Market Outlook

United States and Canada lead the HBsAg Testing market. The market is likely to witness significant growth owing to the high prevalence of acute cases of hepatitis B, availability of advanced diagnostic tools and rising awareness regarding hepatitis testing.

The rapid growth in the Canadian market is owing to the initiatives of the non-government and organizations. For example, the Public Health Agency of Canada conducted the World Hepatitis Day with the aim of growing awareness regarding hepatitis diagnosis. Thus, resulting into a demand surge for hepatitis diagnosis in the country.

Europe Demand Outlook for HBsAg Testing

Europe is second lucrative market and is likely to register a remarkable growth owing to the rising cases of hepatitis B infections, increasing diagnostic product launches, and growing healthcare expenditure in the region.

As per the World Health Organization, Hepatitis B is a contagious disease that affected approximately 15 million people in 2019 in the WHO European region. The growing geriatric population is also increasing the demand for hepatitis testing as complications associated with hepatitis worsen with aging.

Who are the Key Manufacturers and Suppliers of HBsAg Testing?

Some of the leading manufacturers and suppliers of HBsAg Testing include

• CTK Biotech Inc.
• Biopanda Reagents Ltd.
• Avecon Healthcare Pvt Ltd.
• Abbott
• Bio-Rad Laboratories Inc.
• Siemens Healthineers
• QIAGEN
• F. Hoffmann-La Roche AG and others.

The HBsAg Testing market is competitive, with the presence of a few major players. These global market players compete mainly on the basis of technological developments. Moreover, key players are investing greatly in the research and development to develop rapid and advanced diagnostic products.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14155

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

According to the recent research by Future Market Insights, the functional electrical stimulation market is set to witness 8.6% growth during the forecast period from 2021 to 2031. The rising incidences of injury to the central nervous system lead to enhance functional electrical stimulation market during the forecast period from 2021 to 2031. Therefore, there will be significant growth seen in the functional electrical stimulation market.

What is Driving the Demand for Functional Electrical stimulation?

The functional electrical stimulation market is driven by various factors such as rising musculoskeletal disorders, advancement in the technological field such as medical science, the rising importance of pain management therapies in different fields of medicines, and the increasing number of physiotherapists for the disorders of muscle stimulators helps decrease pain, decrease discomfort, restore muscle tone, and rehabilitate various parts of the body.

Also, the unhealthy diet and lack of physical activities and exercise tend to drive the demand for functional electrical stimulation soon.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-14217

Rising Prevalence of Musculoskeletal Disorders Likely to Propel the Growth of Functional electrical stimulation Market

The prevalence of musculoskeletal disorders is rising globally due to unhealthy diet and lack of physical activity which leads to obesity and musculoskeletal disorders.

According to WHO data of February 2021, a total of 1.71 billion people were suffering from musculoskeletal conditions worldwide. Among which low back pain causes the highest burden with a prevalence of 568 million people suffering from the condition globally.

Thus, the demand for functional electrical stimulation will increase significantly with the increasing prevalence of musculoskeletal disorders shortly.

U.S. and Canada Functional Electrical Stimulation Market Outlook

Obesity is related to nervous system disorders and can lead to the condition of stroke also where the blood stops flowing to the brain. In America, the prevalence of obesity is rising due to changing lifestyles such as having unhealthy diet choices and changing sleep schedules.

For instance, according to CDC, the prevalence of obesity increases from 30.5% to 42.4% from 2000 to 2018.

Therefore, the demand for functional electrical stimulation will increase during the forecast period from 2021 to 2031.

Europe Demand Outlook for Functional Electrical Stimulation

The prevalence of the musculoskeletal disorder is high in the region that has a direct positive impact on the electrical stimulation market. For instance, Poland and Hungary are the two European countries with the highest prevalence of musculoskeletal disorder with 6,737 and 6,697 per 100,000 population respectively.

Thus, with the rising musculoskeletal disorder, the demand for functional electrical stimulation also rises in the region.

Who are the Key Manufacturers and Suppliers of Functional Electrical Stimulation?

The key players of functional electrical stimulation include HASOMED GmbH, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, and others.

The above companies follow certain strategies like merger & acquisition, getting FDA approval, and new product launches to be at the top position in the market. For instance, in May 2017, Ottobock collaborated with Bioness for the distribution of the new FES generation from Bioness.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14217

Why Future Market Insights?

•   Comprehensive analysis on evolving purchase pattern across different geographies
•   Detailed insights of market segments and sub-segments for historical as well as forecast period
•   A competitive analysis of prominent players and emerging players in the keyword market
•   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com